IRIS BIOTECHNOLOGIES INC — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c2a4e843-7395-401a-94ed-2290db347816/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-1.2M | 2015-01-01 – 2015-12-31 | evidence 0001554795-16-000602 |
| FY 2014 | $-1.2M | 2014-01-01 – 2014-12-31 | evidence 0001554795-15-000107 |
| FY 2013 | $-9.9M | 1999-02-16 – 2014-03-31 | evidence 0001554795-14-000360 |
| FY 2012 | $-9.3M | 1999-02-16 – 2013-03-31 | evidence 0001554795-13-000293 |
| FY 2011 | $-8.8M | 1999-02-16 – 2012-03-31 | evidence 0001013762-12-001060 |
| FY 2010 | $-1.1M | 2010-01-01 – 2010-12-31 | evidence 0001013762-12-000393 |
| FY 2009 | $-1.1M | 2009-01-01 – 2009-12-31 | evidence 0001013762-12-000393 |
| FY 2008 | $-883.5k | 2008-01-01 – 2008-12-31 | evidence 0001013762-12-000393 |
| FY 2007 | $-397.0k | 2007-01-01 – 2007-12-31 | evidence 0001013762-12-000393 |
| FY 2006 | $-1.1M | 2006-01-01 – 2006-12-31 | evidence 0001013762-12-000393 |
| FY 2005 | $-197.3k | 2005-01-01 – 2005-12-31 | evidence 0001013762-12-000393 |
| FY 2004 | $-205.6k | 2004-01-01 – 2004-12-31 | evidence 0001013762-12-000393 |
| FY 2003 | $-216.8k | 2003-01-01 – 2003-12-31 | evidence 0001013762-12-000393 |
| FY 2002 | $-184.7k | 2002-01-01 – 2002-12-31 | evidence 0001013762-12-000393 |
| FY 2001 | $-266.2k | 2001-01-01 – 2001-12-31 | evidence 0001013762-12-000393 |
| FY 2000 | $-378.0k | 2000-01-01 – 2000-12-31 | evidence 0001013762-12-000393 |
| FY 1999 | $-2.1M | 1999-02-16 – 1999-12-31 | evidence 0001013762-12-000393 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).